000 00992 a2200289 4500
005 20250516125404.0
264 0 _c20130317
008 201303s 0 0 eng d
022 _a1474-4465
024 7 _a10.1016/S1474-4422(12)70304-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDirks, Maaike
245 0 0 _aImplementation of thrombolysis for ischaemic stroke.
_h[electronic resource]
260 _bThe Lancet. Neurology
_cFeb 2013
300 _a120-1 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aFemale
650 0 4 _aFibrinolytic Agents
_xtherapeutic use
650 0 4 _aHospitals, Community
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aStroke
_xdrug therapy
650 0 4 _aTissue Plasminogen Activator
_xtherapeutic use
700 1 _aDippel, Diederik Wj
773 0 _tThe Lancet. Neurology
_gvol. 12
_gno. 2
_gp. 120-1
856 4 0 _uhttps://doi.org/10.1016/S1474-4422(12)70304-6
_zAvailable from publisher's website
999 _c22365064
_d22365064